Nasdaq
GDTC
CytoMed Therapeutics Limited
- Health Care
- Singapore
- Listed 2023
- 1 day
- −4.4%
- 1 month
- −17.2%
- 1 year
- −56.4%
$0.8029 · Mkt cap $9.50M
At the 6 Aug 2026 close
Nasdaq
CytoMed Therapeutics Limited
$0.8029 · Mkt cap $9.50M
At the 6 Aug 2026 close
CytoMed Therapeutics Limited trades under the ticker GDTC on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2023. Its market capitalisation is $9.50M. The last closing price was $0.8029, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −56.4%, and −17.2% over the past month. Returns are price returns and exclude dividends.
This page exists because GDTC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.